Literature DB >> 24496675

Evaluation of carotid plaque neovascularization in patients with diabetes mellitus by contrast-enhanced ultrasonography.

Li Xiong1, Peng Li1, Bo-Wen Zhao2.   

Abstract

This study investigated the relationship between carotid plaque neovascularization and diabetes mellitus (DM) by using contrast-enhanced ultrasonography. Contrast-enhanced ultrasonography was performed in 104 patients with carotid plaque thicker than 2.0 mm. There were 36 patients with DM and 68 patients without DM. The enhanced intensity in the plaque and the ratio of enhanced intensity in the plaque to that in the lumen of the carotid artery in patients with DM were significantly greater than those in patients without DM. Our study demonstrated that the enhanced intensity in patients with DM is greater than that their counterparts without DM, suggesting that carotid plaque in DM patients may have more neovessels and may be more vulnerable.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24496675     DOI： 10.1007/s11596-014-1227-y

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN： 1672-0733


  13 in total

1.  Report of the expert committee on the diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2003-01       Impact factor: 19.112

2.  Detection of carotid adventitial vasa vasorum and plaque vascularization with ultrasound cadence contrast pulse sequencing technique and echo-contrast agent.

Authors:  Edoardo Vicenzini; Maria Fabrizia Giannoni; Francesco Puccinelli; Maria Chiara Ricciardi; Marta Altieri; Vittorio Di Piero; Bruno Gossetti; Fabrizio Benedetti Valentini; Gian Luigi Lenzi
Journal:  Stroke       Date:  2007-08-30       Impact factor: 7.914

3.  Contrast-enhanced ultrasound imaging of intraplaque neovascularization in carotid arteries: correlation with histology and plaque echogenicity.

Authors:  Stefano Coli; Marco Magnoni; Giuseppe Sangiorgi; Massimiliano M Marrocco-Trischitta; Giulio Melisurgo; Alessandro Mauriello; Luigi Spagnoli; Roberto Chiesa; Domenico Cianflone; Attilio Maseri
Journal:  J Am Coll Cardiol       Date:  2008-07-15       Impact factor: 24.094

4.  Oncostatin M-enhanced vascular endothelial growth factor expression in human vascular smooth muscle cells involves PI3K-, p38 MAPK-, Erk1/2- and STAT1/STAT3-dependent pathways and is attenuated by interferon-γ.

Authors:  Svitlana Demyanets; Christoph Kaun; Kathrin Rychli; Stefan Pfaffenberger; Stefan P Kastl; Philipp J Hohensinner; Gersina Rega; Katharina M Katsaros; Taras Afonyushkin; Valery N Bochkov; Matthias Paireder; Igor Huk; Gerald Maurer; Kurt Huber; Johann Wojta
Journal:  Basic Res Cardiol       Date:  2010-12-21       Impact factor: 17.165

5.  Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability.

Authors:  Pedro R Moreno; K Raman Purushothaman; Valentin Fuster; Dario Echeverri; Helena Truszczynska; Samin K Sharma; Juan J Badimon; William N O'Connor
Journal:  Circulation       Date:  2004-09-27       Impact factor: 29.690

6.  Expression of hypoxia-inducible angiogenic proteins (hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and E26 transformation-specific-1) and plaque hemorrhage in human carotid atherosclerosis.

Authors:  Tetsuhiro Higashida; Hiroshi Kanno; Masato Nakano; Kengo Funakoshi; Isao Yamamoto
Journal:  J Neurosurg       Date:  2008-07       Impact factor: 5.115

7.  Evaluation of carotid atherosclerotic plaque stability with contrast-enhanced ultrasonography.

Authors:  Li Xiong; Youbin Deng; Xiaojun Bi; Ying Zhu; Weihui Shentu; Fen Yu; Yun Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-12-24

Review 8.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

Authors:  Morteza Naghavi; Peter Libby; Erling Falk; S Ward Casscells; Silvio Litovsky; John Rumberger; Juan Jose Badimon; Christodoulos Stefanadis; Pedro Moreno; Gerard Pasterkamp; Zahi Fayad; Peter H Stone; Sergio Waxman; Paolo Raggi; Mohammad Madjid; Alireza Zarrabi; Allen Burke; Chun Yuan; Peter J Fitzgerald; David S Siscovick; Chris L de Korte; Masanori Aikawa; K E Juhani Airaksinen; Gerd Assmann; Christoph R Becker; James H Chesebro; Andrew Farb; Zorina S Galis; Chris Jackson; Ik-Kyung Jang; Wolfgang Koenig; Robert A Lodder; Keith March; Jasenka Demirovic; Mohamad Navab; Silvia G Priori; Mark D Rekhter; Raymond Bahr; Scott M Grundy; Roxana Mehran; Antonio Colombo; Eric Boerwinkle; Christie Ballantyne; William Insull; Robert S Schwartz; Robert Vogel; Patrick W Serruys; Goran K Hansson; David P Faxon; Sanjay Kaul; Helmut Drexler; Philip Greenland; James E Muller; Renu Virmani; Paul M Ridker; Douglas P Zipes; Prediman K Shah; James T Willerson
Journal:  Circulation       Date:  2003-10-07       Impact factor: 29.690

9.  Contrast-enhanced ultrasound imaging of atherosclerotic carotid plaque neovascularization: a new surrogate marker of atherosclerosis?

Authors:  Falak Shah; Prakash Balan; Matthew Weinberg; Vijaya Reddy; Rachel Neems; Matthew Feinstein; John Dainauskas; Peter Meyer; Marshall Goldin; Steven B Feinstein
Journal:  Vasc Med       Date:  2007-11       Impact factor: 3.239

10.  Correlation of carotid plaque neovascularization detected by using contrast-enhanced US with clinical symptoms.

Authors:  Li Xiong; You-Bin Deng; Ying Zhu; Ya-Ni Liu; Xiao-Jun Bi
Journal:  Radiology       Date:  2009-03-20       Impact factor: 11.105
View more
  2 in total

1.  Correlation of enhancement degree on contrast-enhanced ultrasound with histopathology of carotid plaques and serum high sensitive C-reactive protein levels in patients undergoing carotid endarterectomy.

Authors:  Li Xiong; Wei-Jun Sun; Hua-Ying Cai; Yuan Yang; Jiang Zhu; Bo-Wen Zhao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-06-06

Review 2.  Role of NFAT in the Progression of Diabetic Atherosclerosis.

Authors:  Yaoyao Cai; Haipeng Yao; Zhen Sun; Ying Wang; Yunyun Zhao; Zhongqun Wang; Lihua Li
Journal:  Front Cardiovasc Med       Date:  2021-03-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.